EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin



Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin



Official Gazette of the United States Patent & Trademark Office Patents 1252(3), Nov 20



The present invention relates to beta-hCG, particularly beta-hCG proteins having a sequence of amino acids 41-54, 45-54, 47-53, 45-57 and 45-58 and analogs and derivatives thereof. The invention further relates to methods of treatment and prevention of HIV infection by administration of a therapeutic compound of the invention. Such therapeutic compounds include hCG, beta-hCG and beta-hCG peptides, analogs and derivatives of hCG, beta-hCG and beta-hCG peptides, and nucleic acids encoding hCG, beta-hCG and beta-hCG peptides. In a preferred embodiment, beta-hCG peptides, particularly beta-hCG peptides of amino acids 47-53, 45-57 or 45-58 are administered to a subject for treatment or prevention of HIV infection in that subject. The invention also provides methods for screening hCG preparations for activity in treating or preventing HIV infection. Pharmaceutical compositions and methods of administration of Therapeutics are also provided.

(PDF 0-2 workdays service: $29.90)

Accession: 035980005

Download citation: RISBibTeXText



Related references

Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin. Official Gazette of the United States Patent & Trademark Office Patents 1229(1), Dec 7, 1999

Plasma levels of luteinizing hormone human chorionic gonadotropin in male subjects following intra venous administration of human chorionic gonadotropin or oral treatment with clomiphene. Acta Endocrinologica Supplementum 159: 109, 1972

Administration of human chorionic gonadotropin to suckled beef cows before ovulation synchronization and fixed-time insemination: replacement of gonadotropin-releasing hormone with human chorionic gonadotropin. Journal of Animal Science 89(10): 3030-3039, 2012

The testicular response to human chorionic gonadotropin and human chorionic gonadotropin human menopausal gonadotropin treatment in patients with hypogonadotropic eunuchoidism influence of endogenous fsh. Journal of Steroid Biochemistry 20(6 PART B): 1603, 1984

Individualized treatment and hormonal patterns during administration of human menopausal gonadotropin human chorionic gonadotropin in anovulatory women. Acta Obstetrica et Gynaecologica Japonica (Japanese Edition) 33(6): 777-785, 1981

The preparation of a human chorionic gonadotropin specific immunoadsorbent using human chorionic gonadotropin beta carboxyl terminal peptide antibody and its application to isolate human chorionic gonadotropin like substances from human pituitary glands. Folia Endocrinologica Japonica 60(6): 800-813, 1984

Monitoring of follicles by ultrasonography during induction with human menopausal gonadotropin human chorionic gonadotropin treatment especially on the prevention of side effects. Acta Obstetrica et Gynaecologica Japonica (Japanese Edition) 37(5): 721-729, 1985

A specific radio immunoassay of a human chorionic gonadotropin beta subunit in the presence of native human chorionic gonadotropin and immunological biological and chemical characterization of human chorionic gonadotropin and its chemically modified subunits. Folia Endocrinologica Japonica 55(1): 38-53, 1979

Fundamental and clinical evaluation of human chorionic gonadotropin radio immunoassay using iodine 125 labeled human chorionic gonadotropin and anti beta human chorionic gonadotropin system. Kaku Igaku 19(4): 607, 1982

Effects of human chorionic gonadotropin asialo human chorionic gonadotropin and human chorionic gonadotropin alpha and beta subunits upon luteinization of monkey granulosa cell cultures. Federation Proceedings: 257, 1972

Effects of human chorionic gonadotropin asialo human chorionic gonadotropin and the subunits of human chorionic gonadotropin upon luteinization of monkey granulosa cell cultures. Endocrinology 93(5): 1035-1043, 1973

Gonadotropin-releasing hormone effects on placental hormones during gestation: I. Alpha-human chorionic gonadotropin, human chorionic gonadotropin and human chorionic somatomammotropin. Biology of Reproduction 34(2): 245-254, 1986

Typical pattern of human chorionic gonadotropin human chorionic gonadotropin alpha and human chorionic gonadotropin beta serum concentrations in molar pregnancies. Acta Endocrinologica Supplementum 212: 33, 1977

The carbohydrate moiety of human chorionic gonadotropin lack of competition with human chorionic gonadotropin for testicular receptors and anti human chorionic gonadotropin serum. Hormone & Metabolic Research 11(2): 165-167, 1979

Rapid human chorionic gonadotropin part 2 time variations in blood luteinizing hormone follicle stimulating hormone testosterone estrogen and dehydroepi androsterone after human chorionic gonadotropin administration. Folia Endocrinologica Japonica 50(2): 316, 1974